focus
Previous article:
BioMarin wins approval for gene therapy to treat hemophilia A
Next article: Drug for rare kidney disease narrowly misses mark in clinical trial
Next article: Drug for rare kidney disease narrowly misses mark in clinical trial
leisure time
focus
-
Test for long Covid? Researchers find new clue in blood samples
2025-08-04 06:40 -
Senators: Long
2025-08-04 06:28 -
How digital therapeutics firms are pivoting after Pear's bankruptcy
2025-08-04 06:09 -
What Congress can do to address the rural doctor shortage
2025-08-04 05:53 -
AstraZeneca, Daiichi breast cancer treatment succeeds in trial
2025-08-04 05:07 -
CDC's new outbreak response network to include Northeastern
2025-08-04 04:58